NESTLEIND
NIFTY50

Nestle India Ltd.

FMCG · NSE

₹1,482.40
1Y+27.0%
P/E81.6
Fwd P/E62.3
ROE+76.3%
Margin+15.1%
D/E8.61
Div Yld+0.8%
Quality Score67/100
Analyst consensus:Constructive· 36 analysts

52-week range

₹1,079₹1,496

From 52w high

-0.9%

RSI (14)

78.5

vs SMA 50 / 200

50 · 200

Nestle India trades at ₹1,482.40, up 27.0% over the past 12 months and near its 52-week high with a drawdown of just -0.93%. The company ranks first among 6 FMCG peers on both ROE (76.34%) and quality score (61), but carries the highest trailing PE in the peer group at 81.55x and an elevated debt-to-equity of 8.61 with a rising debt trend. RSI at 78.51 signals overbought conditions across both the 50-DMA and 200-DMA.

Pros
  • ROE of 76.34% ranks first among the 6-stock FMCG peer set, well above Britannia (53.31%), Hindustan Unilever (21.6%), and Godrej Consumer (15.1%), indicating high capital efficiency relative to peers.
  • Revenue has grown at 23.8% over 5 years and earnings at 27.4% over the same period, reflecting consistent compounding of the top and bottom lines.
  • Quality score of 61 places NESTLEIND at the top of its FMCG peer group (next: HINDUNILVR at 58), and the stock carries a profit margin of 15.11%.
  • Price is 27.0% higher over 12 months and 14.4% higher over 3 months, with price above both the 50-DMA (₹1,293.98) and 200-DMA (₹1,244.37), reflecting sustained positive price momentum.
Cons
  • Debt-to-equity of 8.61 is elevated relative to FMCG norms and the debt trend is classified as rising; this is an atypical capital structure for a consumer staples business and warrants monitoring.
  • ROE persistence data covers only 3 years above 15%, and FCF is positive in only 3 of the available years, making it difficult to assess whether the current profitability metrics are structurally durable.
  • RSI of 78.51 is in overbought territory; the price is 14.5% above the 50-DMA and 19.1% above the 200-DMA, indicating a significant extension from medium- and long-term averages.
  • Trailing PE of 81.55 is the highest in the 6-stock FMCG peer group; the forward PE of 62.28 implies meaningful earnings growth expectations are already embedded in the current price.
Recent context
  • ·Q4 results (reported around April 21, 2026) were described in news coverage as strong, prompting a 3% single-day gain and a record-high stock price; a dividend announcement was made alongside the results, though brokerages were noted as divided on valuation comfort.
  • ·The stock has gained 14.36% over the past 3 months and is within 1% of its 52-week high as of the run date, reflecting continued price strength following the earnings report.
  • ·Nestle India issued an investor alert regarding SEBI's special demat window for physical shares (April 2026), a governance/compliance notice with no direct financial impact flagged in the coverage.
Questions to ask yourself
  • ?Is the elevated debt-to-equity of 8.61 — high by FMCG standards — a structural feature of Nestle India's business model (e.g. inter-company financing, lease obligations) or does it reflect a genuine increase in financial leverage over the past few years?
  • ?Does the 5-year ROE of 76.34% reflect a structural competitive moat specific to Nestle India's brand and distribution, or is it influenced by accounting factors such as a low equity base resulting from high dividend payouts?
  • ?At a trailing PE of 81.55 — the highest in the peer group — what earnings growth rate over the next 3–5 years is implied, and how does that compare to the historical 5-year earnings growth rate of 27.4%?
  • ?Given that RSI is at 78.51 and the price is 19% above the 200-DMA, what has been the historical pattern of mean reversion for NESTLEIND after similar overbought conditions, and how deep have prior consolidation phases been?

PE

81.6

Forward PE

62.3

ROE

+76.3%

Profit margin

+15.1%

D/E

8.61

Dividend yield

+0.8%

Quality score

61/100

ROE 5y above 15%

3/5 yrs

FCF 5y positive

3/5 yrs

Analyst consensus2.42 · 36 analysts(1–5 scale, lower = more constructive)

For informational purposes only. Not investment advice. VivaTrades is not a SEBI-registered Investment Adviser or Research Analyst. Market data sourced from public feeds; consult a registered adviser before any investment decision.Analysis generated 10 May 2026.